BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 20962513)

  • 21. Diagnostic imaging of urothelial cancer.
    Lantz EJ; Hattery RR
    Urol Clin North Am; 1984 Nov; 11(4):567-83. PubMed ID: 6390911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bladder cancer: can imaging change patient management?
    Beyersdorff D; Zhang J; Schöder H; Bochner B; Hricak H
    Curr Opin Urol; 2008 Jan; 18(1):98-104. PubMed ID: 18090497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle.
    Mertens LS; Fioole-Bruining A; Vegt E; Vogel WV; van Rhijn BW; Horenblas S
    BJU Int; 2013 Oct; 112(6):729-34. PubMed ID: 23790129
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 18F-fluorodeoxyglucose--positron emission tomography/computed tomography aids staging and predicts mortality in patients with muscle-invasive bladder cancer.
    Mertens LS; Mir MC; Scott AM; Lee ST; Fioole-Bruining A; Vegt E; Vogel WV; Manecksha R; Bolton D; Davis ID; Horenblas S; van Rhijn BW; Lawrentschuk N
    Urology; 2014 Feb; 83(2):393-8. PubMed ID: 24468513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Value of 11C-choline PET and contrast-enhanced CT for staging of bladder cancer: correlation with histopathologic findings.
    Picchio M; Treiber U; Beer AJ; Metz S; Bössner P; van Randenborgh H; Paul R; Weirich G; Souvatzoglou M; Hartung R; Schwaiger M; Piert M
    J Nucl Med; 2006 Jun; 47(6):938-44. PubMed ID: 16741302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Staging bladder cancer.
    Husband JE
    Clin Radiol; 1992 Sep; 46(3):153-9. PubMed ID: 1395418
    [No Abstract]   [Full Text] [Related]  

  • 27. Imaging in genitourinary cancer from the urologists' perspective.
    Tsakiris P; de la Rosette J
    Cancer Imaging; 2007 May; 7(1):84-92. PubMed ID: 17535776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Staging and prognosis of T3b bladder cancer.
    Levy DA; Grossman HB
    Semin Urol Oncol; 1996 May; 14(2):56-61. PubMed ID: 8734732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Transurethral ultrasonography, CT scan, nuclear magnetic resonance (NMR) imaging and pathological control in staging and follow up of invasive bladder carcinoma.
    Pavone C; Di Trapani D; Serretta V; Filosto L; Cacciatore M; Caramia G; Pavone-Macaluso M
    Prog Clin Biol Res; 1988; 260():251-63. PubMed ID: 3283763
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Imaging and pathology of bladder tumors].
    Roy C; Merran S
    J Radiol; 2002 Jun; 83(6 Pt 2):843-59, discussion 861-2. PubMed ID: 12218858
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of imaging techniques in the diagnosis and follow-up of muscle-invasive bladder carcinoma.
    Mesa A; Nava E; Fernández Del Valle A; Argüelles B; Menéndez-Del Llano R; Sal de Rellán S
    Actas Urol Esp (Engl Ed); 2018 Sep; 42(7):425-434. PubMed ID: 29029769
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Imaging studies for germ cell tumors.
    Sohaib SA; Cook G; Koh DM
    Hematol Oncol Clin North Am; 2011 Jun; 25(3):487-502, vii. PubMed ID: 21570604
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Positron emission tomography and positron emission tomography/computerized tomography of urological malignancies: an update review.
    Bouchelouche K; Oehr P
    J Urol; 2008 Jan; 179(1):34-45. PubMed ID: 17997425
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pancreatic cancer: current concepts in imaging for diagnosis and staging.
    Tamm E; Charnsangavej C
    Cancer J; 2001; 7(4):298-311. PubMed ID: 11561606
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Urology imaging: contribution of imaging in bladder tumors].
    Descotes JL; Hubert J; Lemaitre L
    Prog Urol; 2003 Nov; 13(5):947-68. PubMed ID: 14763391
    [No Abstract]   [Full Text] [Related]  

  • 36. Positron Emission Tomography/Computed Tomography for Staging of Bladder Cancer: A Continuing Clinical Controversy.
    Mertens LS; Meijer RP; Alfred Witjes J
    Eur Urol; 2023 Feb; 83(2):95-96. PubMed ID: 36202686
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Current trends in the diagnosis of tumors of the bladder].
    Alberti C; Potenzoni D; Cortellini P; Paolucci R
    Minerva Chir; 1987 Dec; 42(23-24):1955-61. PubMed ID: 3329305
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparative effectiveness of imaging modalities for the diagnosis of upper and lower urinary tract malignancy: a critically appraised topic.
    Razavi SA; Sadigh G; Kelly AM; Cronin P
    Acad Radiol; 2012 Sep; 19(9):1134-40. PubMed ID: 22717592
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Tumors of the urinary bladder: technique, current use, and perspectives of MR and CT cystography.
    Beer A; Saar B; Rummeny EJ
    Abdom Imaging; 2003; 28(6):868-76. PubMed ID: 14753610
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advances in Imaging in Prostate and Bladder Cancer.
    Srivastava A; Douglass LM; Chernyak V; Watts KL
    Curr Urol Rep; 2017 Sep; 18(9):69. PubMed ID: 28718164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.